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Abstract
Intercellular communication orchestrates effective immune
responses against disease-causing agents. Extracellular vesicles
(EVs) are potent mediators of cell–cell communication. EVs carry
bioactive molecules, including microRNAs, which modulate gene
expression and function in the recipient cell. Here, we show that
formation of cognate primary T-B lymphocyte immune contacts
promotes transfer of a very restricted set of T-cell EV-microRNAs
(mmu-miR20-a-5p, mmu-miR-25-3p, and mmu-miR-155-3p) to the
B cell. Transferred EV-microRNAs target key genes that control
B-cell function, including pro-apoptotic BIM and the cell cycle
regulator PTEN. EV-microRNAs transferred during T-B cognate
interactions also promote survival, proliferation, and antibody class
switching. Using mouse chimeras with Rab27KO EV-deficient T
cells, we demonstrate that the transfer of small EVs is required for
germinal center reaction and antibody production in vivo, revealing
a mechanism that controls B-cell responses via the transfer of EV-
microRNAs of T-cell origin. These findings also provide mechanistic
insight into the Griscelli syndrome, associated with a mutation in
the Rab27a gene, and might explain antibody defects observed in
this pathogenesis and other immune-related and inflammatory
disorders.
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Introduction
Antigen-driven immune contacts between B lymphocytes and T
lymphocytes are required to trigger the germinal center reaction
(GC) that gives rise to high-affinity antibodies. This process plays a
pivotal role in the development of humoral immunity, and its defi-
ciency leads to immune-related pathologies. Among primary
immune deficiencies, antibody production-related diseases are the
most frequent and clinically relevant [1]. Communication between
immune cells coordinates an effective immune response to eliminate
pathogens while maintaining physiological homeostasis. Informa-
tion travels through cell contact-dependent and cell contact-indepen-
dent mechanisms. These mechanisms must ensure the transfer of
information, usually biomolecules, between neighboring and distant
cells. A classical example of a contact-dependent mechanism is the
formation of immune synapses (IS), while contact-independent
mechanisms include the release of cytokines and extracellular vesi-
cles (EVs). In recent years, EVs have emerged as key modulators of
cell signaling. EVs include vesicles of endosomal origin called
exosomes. EVs carry lipids, proteins, and nucleic acids, in particular
small RNA species such as microRNAs (miRNAs), which regulate
gene expression in recipient cells [2].
The IS is a highly specialized platform that enables contact-
dependent information exchange between a T lymphocyte and an
antigen-presenting cell (APC). Our previous work showed that IS
formation promotes the polarized transfer of EVs from the T cell to
the APC. T cell-origin EVs are enriched in the T-cell receptor (TCR)
[3] and functional miRNAs that down-modulate specific target
mRNAs in the recipient APC [4]. Although most studies of the IS
have focused on T-cell activation and function, several reports indi-
cate that IS formation induces changes in the APC that appear to be
important for regulating the immune response. Specifically,
dendritic cell apoptosis is decreased after IS formation through a
mechanism that depends on NF-jB and FOXO1 [5]. Recently, we
demonstrated that post-synaptic dendritic cells acquire antiviral
features after receiving mitochondrial DNA from T cell-derived vesi-
cles through the IS [6].
In the case of B cells, interactions with CD4+ T cells are critical
to trigger the germinal center (GC) response. In the dark zone of
GCs, B cells engage in intense proliferation coupled to somatic
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hypermutation (SHM). In the light zone, higher affinity B-cell clones
generated by SHM are competitively selected by interaction with
follicular T helper cells. In addition, GC B cells can exchange their
primary immunoglobulin (Ig) IgM/IgD B-cell receptors by class
switch recombination (CSR), giving rise to B cells with specific Ig
isotypes and therefore specialized effector functions. As a result of
these events, the GC produces high-affinity antibody-secreting
plasma cells and long-lived memory B cells [7].
MiRNAs play an important role in the regulation of B lymphocyte
development, maturation, and function, including B-cell activation,
malignant transformation, the generation of GC B cells, and anti-
body production [8,9].
In this study, we investigated the effects of EV transfer from
CD4+ T cells to B lymphocytes during IS formation, focusing on
miRNA delivery and the impact of transferred miRNAs on the fate
and function of recipient B cells. Using an in vitro model that
enables IS formation between OVA-specific OT-II CD4+T cells and
miRNA-deficient DICER-KO B cells, we identified 3 EV-miRNAs that
are shuttled from the T cell to the B cell in the context of the IS and
contribute to CSR and proliferation in post-synaptic B cells. In addi-
tion, we found that T to B EV transfer is critical for GC progression
and antibody secretion in vivo. Our results provide mechanistic
insight into a novel mode of regulating B-cell adaptive immune
responses based on T-cell EV-miRNA transfer during IS formation,
which may be involved in immune maladies associated with abnor-
mal antibody production. A better understanding of the mechanisms
underlying GC reaction dynamics may pave the way to new thera-
peutic strategies to modulate humoral responses.
Results and Discussion
IS formation promotes class-switch, proliferation, and survival of
B lymphocytes
To assess whether miRNAs are specifically transferred from the
CD4+ T cell to the B lymphocyte during IS formation and potentially
impact B-cell fate and function, the following model was estab-
lished. Briefly, we co-cultured CD4+ T cells isolated from OT-II mice
(which express an OVA-specific transgenic T-cell receptor) with pre-
activated B cells from CD19-CreKi/+ Dicerfl/fl mice (DICER-KO). The
B cells in these mice are DICER-deficient and thus unable to produce
mature miRNAs, allowing identification of exogenously transferred
miRNAs after IS formation (Fig EV1A). Formation of a functional,
mature IS in the presence of OVA peptide, hereafter OVA, was
assessed by confocal microscopy (Fig 1A), revealing an increase in
the percentage of B cells forming conjugates, TCR, and actin recruit-
ment to the contact zone between the CD4+ T cell and the B
lymphocyte, and polarization of the T-cell microtubule-organizing
center (MTOC) toward the IS (Fig 1B–E).
To analyze the effects on B-cell activation and class switch
recombination (CSR) in vitro, we used alternative B-cell stimuli
before co-culture: LPS plus IL-4 to activate Toll-like receptors or
CD40 plus IgM to engage the B-cell receptor (Fig EV1A). OT-II T:B
cell co-culture in the presence of OVA boosted T-cell proliferation in
both setups, especially in the LPS plus IL-4 condition (Fig EV1B and
C). Co-culture also affected B cells, with the number of IgG1-expres-
sing B cells significantly increased after 24 h OVA exposure
(Fig 1F). Importantly, co-culture with OT-II T cells and OVA
increased the percentage of proliferating B cells, as measured by
Ki67 staining and cell violet tracer dilution (Fig 1G and H) as well
as B lymphocyte survival 72 h after IS (Fig 1I), correlating with a
lower percentage of apoptotic B cells, expressing cleaved caspase-3
(Fig 1J). Thus, the formation of a mature IS promoted CSR to the
IgG1 class and promoted B-cell survival and proliferation in vitro.
IS-dependent transfer of a specific set of miRNAs from the T to
the B lymphocyte
Sequencing of the small RNA content in DICER-KO B cells after T-
cell co-culture identified a very restricted set of 6 miRNAs signifi-
cantly increased in B cells upon IS formation in the presence of OVA
(Fig 2A and B, Dataset EV1). The transfer of such a specific set of
miRNAs implies either that shuttled EVs bear only these specific
miRNAs or more likely, that these miRNAs, which may be impor-
tant for B-cell function, are stabilized in post-synaptic B cells, while
the rest are degraded and/or expelled.
We focused on the 3 miRNAs conserved in humans: mmu-miR-
20a-5p, mmu-miR-25-3p, and mmu-miR-155-3p (Fig EV2A). It is
worthwhile mentioning that, although we focused on the upregu-
lated miRNAs identified in our study, it is likely that other T-cell EV-
miRNAs may also have a role in recipient B lymphocytes. Although
DICER-KO B cells can retain low levels of miRNAs, as previously
described [10,11], small RNA sequencing revealed that the
increased levels of mmu-miR-20a-5p, mmu-miR-25-3p, and mmu-
miR-155-3p were only found after IS formation (Fig EV2C). In addi-
tion, we observed no changes in residual Dicer expression in
DICER-KO B cells upon OVA exposure (Fig EV2B). Moreover, in the
absence of T-cell contact, B cells from DICER-KO (CD19CreKi/+
Dicerfl/fl) mice showed very low levels of mmu-miR-20a-5p, mmu-
miR-25-3p, and mmu-miR-155-3p (Fig EV2D) both before and after
stimulation with LPS and IL-4. Also, mmu-miR-20a-5p and mmu-
miR-155-3p increased upon LPS+IL-4 B-cell stimulation in WT B
lymphocytes but not in DICER-KO B cells, while mmu-miR-25-3p
was downregulated after stimulation, in agreement with previously
published data [12]. Thus, miRNA upregulation in DICER-deficient
B cells cannot be attributed to B-cell stimulation, and instead is trig-
gered by the OVA-specific IS.
Importantly, these miRNAs are expressed in activated T cells
from wild-type C57BL/6 mice and in their secreted small EVs
(Fig 2C and D, Dataset EV2). Mmu-miR-20a-5p, mmu-miR-25-3p,
and mmu-miR-155-3p could also be detected in small EVs derived
from OT-II CD4+ T-cell cultures, isolated from CD63- and CD81-
expressing size-exclusion chromatography fractions and ultracen-
trifuged supernatants but not in culture medium alone, excluding
possible serum contaminations in these samples (Fig EV3). The bias
of small RNA sequencing protocols for particular miRNAs should be
taking into account when analyzing the EV-enrichment scores
(Fig EV2A).
Quantitative real-time PCR (qRT–PCR) of mmu-miR-20a-5p,
mmu-miR-25-3p, and mmu-miR-155-3p confirmed increased content
after IS formation in DICER-KO B-cells pre-activated with LPS plus
IL-4 (Fig 2E) and especially after pre-activation with CD40 plus IgM
(Fig 2F). Mmu-miR-20a-5p and mmu-miR-25-3p were significantly
more abundant in EVs than in their secreting cells (Fig EV3A), in
agreement with the existence of specific mechanisms for miRNA
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sorting into EVs [13,14]. Accordingly, the 3 identified miRNAs are
upregulated in CD4+ activated T cells and effector T-cell subsets
and are expressed in follicular helper T cells [12,15]. A recent report
indicates that abundance of these miRNAs also increases during dif-
ferentiation to antibody-producing plasma B lymphocytes in
humans [16]. Activated B lymphocytes also secrete miRNA-
containing EVs. However, given the low levels of mature miRNAs in
DICER-KO B cells (Fig EV2) and previous work demonstrating the
unidirectionality of IS-dependent EV transfer [4], we have focused
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In silico target analyses for these miRNAs identified putative
mRNA targets with pro-apoptotic effects, for example, BCL2L11
(BIM). The prediction algorithms also identified molecules that
participate in B-cell homeostasis downstream of BCR signaling, for
example, Pten, and several cell cycle regulators, including Tp53 and
CCND1 and cyclin-dependent kinases, with important roles in GC
reaction, such as CDKN1C/p57 [17] (Appendix Table S1).
qRT–PCR experiments revealed that some of these putative target
mRNAs were downregulated upon IS formation in the presence of
OVA (Figs 2G and H, and EV2E and F). In particular, increased
miRNA transmission correlated with downregulation of molecules
crucial for B lymphocyte biology, such as BIM and PTEN, which
decreased more steeply in the CD40 plus IgM (Fig 2H) than in the
LPS plus IL-4 B-cell co-cultures (Fig 2G). However, other predicted
targets did not change their expression levels, for example, TP53
and MDM2 (Fig EV2E and F). Notably, the down-modulated targets
of these miRNAs are involved in B-cell proliferation, survival, and
GC reaction [17].
To characterize the function of transferred miRNAs in recipient
B cells, we nucleofected B cells from wild-type C57BL/6 mice
with synthetic mimic miRNAs fluorescently labeled with FAM.
qPCR analysis confirmed the specific increase in mature miRNAs
in FAM+ FACS-sorted nucleofected cells (Fig 2I). In addition,
qRT–PCR detected specific downregulation of BIM mRNA after
nucleofection with mmu-miR-20a-5p or mmu-miR-25-3p but not
mmu-miR-155-3p (Fig 2J), in accordance with algorithm-based
predicted targets (Appendix Table S1). Likewise, PTEN mRNA
levels decreased with all 3 transferred miRNAs, as predicted.
FAM+ B cells nucleofected with mmu-miR-20a-5p had increased
switched IgG1 expression (Fig 2K), increased proliferation rate
detected by cell violet tracer dilution and Ki67 expression
(Fig EV4A–C), and survival (Fig EV4D). Interestingly, miR-20a-5p
has been found to be upregulated in the early phases of B-cell
differentiation from memory B cell to pre-plasmablast, subse-
quently decreasing during the transition from plasmablast to
plasma cells [16]. The transfer of this specific miRNAs via the IS
may thus contribute to plasma cell differentiation during early
stages, shortly after antigen recognition.
Similar results were obtained using a retroviral system to express
the precursor sequences of mmu-miR-25 in LPS plus IL-4-activated
◀ Figure 1. Mature IS formation between DICER-KO B cells and OT-II T cells promotes class switching, proliferation, and survival.DICER-KO B cells were co-cultured for 24 h with OTII-derived T cells in the presence or absence of OVA.
A Representative confocal microscopy images of CMAC-stained conjugates formed between B lymphocytes (isolated from DICER-KO mouse splenocytes and pre-
activated with a mixture of LPS plus IL-4) and CD4+ T cells (from OVA-specific OT-II transgenic mice); conjugates were formed either in the presence or in the
absence of OVA. A representative experiment of at least three independent experiments is shown.
B–E Quantification of three representative experiments as in (A), showing the percentage of B cells forming conjugates (B), the accumulation at the IS of the TCR (C)
and actin (D) at the IS, and the distance from the CD4+ T-cell MTOC to the contact site with the B cell (E). Conjugates were assessed using the ImageJ plug-in for IS
analysis, and MTOC–B-cell distance was measured with Imaris analysis software. Bar charts are representative of the mean of n ≥ 7 cells analyzed  SEM from at
least 3 independent experiments. Significance was assessed by unpaired Student’s t-test; *P < 0.05, **P < 0.01, ***P < 0.001.
F–J Flow cytometry analysis of B lymphocytes co-cultured with OT-II isolated T cells in the presence or absence of OVA, showing (F) IgG1 expression after 24 h of co-
culture, (G and H) B-cell proliferation after 24, 48 and 72 h co-culture (Ki67 expression in live B cells and cell violet tracer dilution, respectively), (I) survival (staining
with the live marker DAPI), and (J) apoptosis (cleaved Caspase-3 expression) 24, 48 and 72 h after IS formation.
Data information: Dot plots are representative of ≥ 4 independent experiments 48 h after IS formation, and bar charts show mean values  SEM of at least three
independent experiments at the indicated time points. Significance was assessed by paired Student’s t-test; *P < 0.05, **P < 0.01, ***P < 0.001.
▸Figure 2. mmu-miR-20a-5p, mmu-miR-25-3p, and mmu-miR-155-3p are transferred during IS and correlate with BIM and PTEN down-modulation in Blymphocytes.
CD4+ T and DICER-KO B cells were co-cultured for 24 h with or without OVA, and flow cytometry-sorted B cells were analyzed by small RNA next-generation sequencing
(NGS).
A Heat map showing miRNAs significantly upregulated in B cells after co-culture with T cells in the presence of OVA. Data are from three independent experiments
(samples 1–3), and only miRNAs with an adjusted P < 0.02 are shown.
B Fold increase in the B-cell content of upregulated miRNAs in the presence of OVA; *P < 0.05, **P < 0.01, ***P < 0.001.
C Heat map showing NGS analysis of miRNAs differentially expressed in activated WT C57BL/6 CD4+ T cells and their secreted exosomes. Data are from three
independent experiments (samples a–c), and only miRNAs with an adjusted P < 0.02 are shown.
D Mean tags per million (TPMs) for the differentially expressed miRNAs under study in exosomes from activated CD4+ T cells. Bars represent the mean  SEM.
E, F Quantitative real-time PCR of upregulated miRNAs after co-culture of OT-II derived CD4+ T cells with DICER-KO B cells activated either with LPS+IL-4 (E) or with
CD40+IgM (F). Bars represent the mean  SEM of at least three independent experiments, and data were obtained by the 2ΔΔCt method using Biogazelle
software. Results are expressed as a proportion of the miRNA expression in non-OVA containing co-cultures, with normalization to the small nucleolar RNAs
RNU1A1 and RNU5G.
G, H Quantitative real-time PCR showing the expression of down-modulated mRNA targets upon IS formation between OT-II CD4+ T cells and DICER-KO B cells pre-
activated with either LPS+IL-4 (G) or CD40+IgM (H). Results are the means  SEM of at least four independent experiments and are expressed as a proportion of
mRNA expression in the non-OVA condition, with normalization to GAPDH.
I, J Fluorescently tagged mimics of the miRNAs mmu-miR-20a-5p, mmu-miR-25-3p, and mmu-miR-155-3p were nucleofected into activated B lymphocytes from C57/
BL6 mice. Quantitative real-time PCR showing expression of nucleofected miRNA mimics in FACS-sorted FAM+ B cells with normalization to RNU1A1 and RNU5G
(I); and Bcl2l11 and Pten mRNA targets in mimic-nucleofected B cells with normalization to GAPDH (J). A representative experiment is shown of 4 performed, and
bar charts summarize the mean  SEM. Significance was assessed by paired Student’s t-test comparing the plus and minus OVA conditions; *P < 0.05, **P < 0.01,
***P < 0.001.
K Flow cytometry analysis of mimic-nucleofected B lymphocytes. Dot-plots show B220+ IgG1+ B cells 48 h after mimic nucleofection from at least four independent
experiments, and bar charts show mean values  SEM of four independent experiments.
Data information: Significance was assessed by the Student’s t-test comparing the OVA and NO OVA conditions; *P < 0.05, **P < 0.01, ***P < 0.001.
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B cells, including increased CSR to IgG1 and increased proliferation
and survival (Fig EV4E–J).
EV transfer of CD4+ T-cell miRNAs to B cells is required for
efficient B-cell activation and germinal center reaction and
antibody production in vivo
To examine the role of EV transfer in CSR to IgG1 in B cells, we
blocked exosome release from CD4+ T cells before IS formation
using both genetic and chemical approaches. First, OTII-derived
cells were nucleofected with a small-interfering RNA targeting
Rab27a, a critical mediator of the exosome secretory pathway [18–
21]. After IS formation using siRab27a-treated T cells, miRNA upreg-
ulation was reduced in co-cultured DICER-KO B cells (Fig 3A),
correlating with a slight increase in Bcl211 and Pten mRNAs
(Fig 3B) and a reduced proportion of IgG1+ cells (Fig 3C). B-cell
activation was similarly inhibited after IS formation with T cells
treated with manumycin A, a chemical inhibitor of neutral sphin-
gomyelinase 2 that suppresses exosome biogenesis and secretion
[4,6] (Fig EV5A–C). We conclude that EV-miRNA transfer impacts
activation and differentiation of primary B cells in vitro.
To evaluate the role of T-cell EVs in establishing the GC reaction
in vivo, we conducted adoptive transfer experiments. CD4+ T cells
were isolated from wild-type C57BL/6 mice and from mice deficient
for Rab27a and Rab27b (Rab27-KO), and B cells were obtained from
WT C57BL/6 mice. Isolated T and B cells were co-transferred into
sublethally irradiated Rag1-KO mice, which lack both B and T
mature lymphocytes. Reconstituted mice were inoculated with
sheep red blood cells, and serum and spleens were analyzed after
7 days (Fig 3D). Repopulation of the B- and T-cell compartments
was indistinguishable in mice adoptively transferred with Rab27-KO
or WT T cells (Fig 3E). Assessment of B-cell function revealed that
GC Fas+ GL7+ B cells were less abundant in mice reconstituted
with Rab27-KO-derived T cells than in those reconstituted with WT
T cells, indicating that T cell-derived EV transfer contributes to GC
generation and maintenance in vivo (Fig 3F). Furthermore, GC
Fas+GL7+ B cells of mice adoptively transferred with Rab27-KO
CD4+ T cell had an altered dark zone: light-zone ratio (Fig 3G),
consistent with dysfunctional GC dynamics. Finally, serum ELISA
showed a significant reduction in the production of both soluble
IgM (Fig 3H) and class-switched IgG (Fig 3I), revealing the impor-
tance of EV-dependent B- and T-cell communication for antibody
responses in vivo. Interestingly, a human immunodeficiency featur-
ing decreased antibody production described by Griscelli et al [22]
is associated with a mutation that causes deficiency in Rab27a. This
defect is not B cell-intrinsic, but instead secondary to impairment of
CD4+ T-cell helper function. In this regard, our results suggest that
the antibody defects in Griscelli syndrome are likely the result of
deficient exosome delivery from T cells during their contact with B
cells. T-cell Rab27a deficiency also underlies the Ashen mouse
model, in which cytotoxic T lymphocytes display diminished lytic
functions due to a Rab27a splicing mutation that causes defective
granule exocytosis [23,24]. Moreover, Rab27KO mice have deficient
neutrophil chemotaxis and recruitment [20], impaired granule
exocytosis in neutrophils [21] and mast cells [25], and a chronic
inflammatory phenotype [26]. The deficiency in the B-cell compart-
ment identified in the present study warrants further investigation.
We report a novel mechanism for the regulation of the B-cell
response through the directional transfer of a surprisingly very
restricted set of T-cell exosomal miRNAs (mmu-miR-20a-5p, mmu-
miR-25-3p, and mmu-miR-155-3p) during B:T cell IS. These exoso-
mal miRNAs modulate key mRNA targets in B cells (including BIM
and PTEN) and promote GC regulation, including CSR, B-cell prolif-
eration, and survival (Fig 3J). In accordance with our data, the
combined downregulation of BIM and PTEN has been shown to
promote the GC reaction both in double heterozygous hCD2-iCre;
Ptenfl/+;Bim+/ mice and in transgenic mice over-expressing the
miR-17~92 cluster that targets both proteins [17]. Also, a higher
proliferation and reduced activation-induced cell death were
observed, revealing the key role that modulation of these molecules
plays in T cell-dependent immune responses. In agreement with our
findings, these miRNAs are 2- to 4-fold more abundant in GC B cells
than in mature B cells [12]. Interestingly, the B lymphotropic
Epstein–Barr (EBV) virus has been shown to promote infected naı̈ve
B lymphocyte migration to the GC [27]. This correlates with high
expression of virally encoded miRNAs that target several mRNAs,
including PTEN, which undergoes dramatic decreases at the protein
level upon infection [28].
▸Figure 3. EV transfer is required for full B-cell activation and antibody production in vivo.A Quantitative real-time PCR (RNU1A1 and RNU5G-normalized) showing blockade of miRNA transfer from CD4+ T cells pre-treated with siRNA targeting the exosome
secretion mediator Rab27. Bar charts represent the mean values  SEM of at least four independent experiments.
B Quantitative real-time PCR showing mRNA target down-modulation after IS formation between DICER-KO B cells and CD4+ T cells nucleofected with either siRab27
or scrambled control siRNA, with normalization to GAPDH. Bar charts represent the mean values  SEM of at least four independent experiments.
C Representative dot-plots, showing IgG1 expression of gated B220+ B cells after IS formation as in (G); the bar chart shows the mean fluorescence Intensity  SEM
and quantification of three independent experiments is shown.
D Experimental design. Rag1KO mice were adoptively transferred with WT B lymphocytes and either Rab27-KO T cells (top) or WT T cells. Thereafter mice were
inoculated with sheep red blood cells, and spleens and serum were harvested after 7 days.
E Representative plot (left) and quantification (right) of the reconstitution of the B-cell and T-cell compartments after adoptive transfer. The graph shows the mean
percentage of CD19- and CD4-positive cells from n ≥ 5 reconstituted mice  SEM.
F Representative flow cytometry plot (left) and quantification (right) of GL7 and CD95/Fas expression in B cells. The graph shows the mean percentage of GL7+Fas+
cells from n ≥ 5 reconstituted mice  SEM.
G Representative dot-plot analysis showing CXCR4 and CD86 expression on B cells for dark zone (DZ) and light zone (LZ) analysis (gated on GC GL7+ Fas+ B cells). The
graph shows the mean percentage of DZ (CXCR4+CD86) and LZ (CXCR4CD86+) populations from n ≥ 5 reconstituted mice  SEM.
H, I ELISA quantification of IgM (H) and IgG (I) in serum from immunized adoptively transferred mice. The graph shows the mean serum concentration of IgM and IgG
from n ≥ 5 reconstituted mice, respectively  SEM.
J Proposed model of exosomal miRNA transfer during cognate B- and T-cell interactions.
Data information: Significance was assessed by unpaired Student’s t test comparing the OVA and NO OVA conditions; *P < 0.05.
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Our study thus represents an additional layer of complexity in
the regulation of immune responses during IS formation, and a
better understanding of the mechanisms underlying this process




B cell-specific DICER-deficient (CD19-Creki/+Dicerfl/fl) mice (DICER-
KO mice) were generated by crossing Dicerfl/fl mice with CD19-
Creki/+ [10,11,29] mice. DICER-KO, WT C57BL/6m, and OT-II mice
were housed in specific pathogen-free conditions according to Euro-
pean Commission recommendations at the Centro Nacional de
Investigaciones Cardiovasculares (CNIC) animal facility in Madrid.
Experiments were performed with male and female mice aged 7–
14 weeks. Rab27a/b double KO mice [19] and WT littermates used
as a CD4+ T-cell source in adoptive transfer experiments were
generated by Miguel C. Seabra and housed in specific pathogen-free
conditions according to European Commission recommendations at
the Champalimaud Centre for the Unknown in Lisbon. All experi-
mental methods and protocols were approved by the CNIC and the
Comunidad Autónoma de Madrid and conformed to European
Commission guidelines and regulations.
In vitro cell culture, antibodies, and reagents
Primary cells were isolated by mechanical disruption of cell
suspensions of spleen (and also lymph nodes in the case of
CD4+ T-cell isolation). B cells from DICER-KO and C57/BL6 wild-
type mice were isolated by immunomagnetic depletion with anti-
CD43 beads (Miltenyi). During the 24 h before co-culture, isolated
B cells were cultured in EV-depleted complete RPMI medium [EV-
free RPMI supplemented with 10% EV-depleted fetal bovine
serum (discarding the pellet after ultracentrifugation for 16 h at
100,000 g), 50 lM b-mercaptoethanol (Invitrogen), 10 mM Hepes
(Invitrogen), and antibiotics]. The same batch of ultracentrifuged
EV-depleted serum was used for all experiments to minimize vari-
ability and checked by NanoSight for EV depletion. For B-cell
pre-activation, this medium was supplemented either with 25 lg/
ml LPS (Sigma) and 10 ng/ml IL-4 (Peprotech) or with 10 lg/ml
CD40 and 10 lg/ml F(ab)’2 fragments of goat anti-mouse IgM
(Jackson Immunoresearch). Regardless of the activation method,
the B cells were incubated in the presence or absence of 5 lg/ml
OVA peptide 323–339 (GenScript). For OT-II-derived CD4+ T-cell
isolation, splenocytes and lymph node cells were incubated for
16 h in EXO-free RPMI medium supplemented with 5 lg/ml of
OVA, and T cells were then purified using the CD4+ T-cell isola-
tion kit (Miltenyi Biotec). Antibodies and primers are listed in
Appendix Table S2.
Immune synapse co-cultures
Pre-activated DICER-KO B cells and CD4+ T cells isolated from OT-
II mice were co-cultured at a 1B: 4T cell ratio in EXO-free RPMI
medium either in the presence or absence of 5 lg/ml OVA peptide
323–339. After the times indicated in each individual experiment, B
cells were isolated by flow cytometry cell sorting.
Confocal microscopy
B cells isolated from DICER-KO mice were pre-activated for 24 h,
washed once with HBSS, and stained with 10 lM cell-tracker blue
CMAC (Invitrogen). The B cells (6.25 × 104) were washed and
resuspended in 100 ll EXO-free RPMI complete medium and mixed
with 250,000 OT-II-isolated CD4+ T cells (as described above for co-
cultures) on poly-L-lysine-coated coverslips and allowed to settle for
1 h at 37°C. Thereafter, conjugates were fixed with 4%
paraformaldehyde for 20 min and blocked and permeabilized at
room temperature with 0.2% Triton X-100 in staining buffer
[60 mM PIPES, 25 mM Hepes, 5 mM EGTA, 2 mM MgCl2, 3%
bovine serum albumin, 100 lg/ml c-globulin, and 0.2% azide].
Cells were then incubated in staining buffer containing 5 lg/ml
Alexa Fluor 568-conjugated phalloidin, 0.1 lg/ml fluorescein isoth-
iocyanate (FITC)-conjugated anti-a-tubulin, and biotinylated anti-
va2 antibody followed by streptavidin-labeled Alexa Fluor 647. The
fixed and stained conjugates were mounted in Prolong Gold and
analyzed under a Leica SP5 confocal microscope (Leica) fitted with
a HCX PL APO × 63/1.40–0.6 oil objective. Images were processed
and assembled using ImageJ (https://imagej.nih.gov/ij/) and Photo-
shop. For quantification in an individual IS, we used a specifically
designed ImageJ plugin for synapse measurements, as described in
[30]. MTOC polarization to the IS was assessed by measuring the
distance from the CD4+ T-cell MTOC to the contact site with the B
cell using Imaris software.
RNA extraction, real-time PCR, small RNA next-generation
sequencing (NGS), and data analysis
Flow cytometry-purified cells or post-synaptic CD4+ T cell-derived
EVs were lysed in QIAZOL lysis buffer, and RNA was extracted
using the miRNeasy Mini Kit (QIAGEN).
For small RNA sequencing, RNA integrity was checked using an
Agilent 2100 Bioanalyzer (Agilent) for total RNA (RNA nano-chips)
and for small RNA (small RNA chips), and concentrations were
measured in a Nanodrop-1000 and using the Quantifluor RNA
system (Promega). Three independent experiments were analyzed,
with an RNA integrity number (RIN) ranging from 9 to 10, and small
RNA libraries were generated using the NEBNext Small RNA Library
Prep Set from Illumina. Single read NGS was performed using an
Illumina HiSeq 2500 System.
Small RNASeq data were analyzed by the Bioinformatics Unit at
CNIC. Sequencing reads were processed with a pipeline that used
FastQC, to assess read quality, and Cutadapt to trim sequencing
reads, eliminating Illumina adaptor remains, and to discard reads
that were shorter than 20 bp or had not been trimmed at all. Result-
ing reads were aligned against a mouse sequence database consist-
ing of the mature miRNA component of miRBase21, using
parameters optimized for very short sequence alignments, with
either bowtie or BWA. Expression was then quantified with RSEM
[31], to obtain matrices consisting in either raw expected counts or
TPM (transcripts per million). Raw counts were processed with
an analysis pipeline that used Bioconductor package EdgeR [32]
for normalization (using TMM method, with parameter
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log-ratioTrim = 0.4) and differential expression testing, taking into
account only those small RNAs expressed at a minimal level of 1
CPM in a number of samples equal to the number of replicates of
the condition with less replicates. When required, a blocking vari-
able was used to define groups of samples that were expected to be
similar. Changes in small RNA expression were considered signifi-
cant when Benjamini and Hochberg adjusted P < 0.2.
RNA was retrotranscribed using either the miRCURY LNA
Universal RT miRNA PCR System (EXIQON) for miRNA or the
Promega RT kit for mRNA. Real-time (RT)–PCR was performed in a
CFX384 Real-time System (Bio-Rad) using SYBR Green PCR Master
Mix (Applied Biosystems). Reactions were analyzed with Biogazelle
QbasePlus software. Mature miRNA levels were normalized to the
small nucleolar RNU1A1 and RNU5G [13], whereas mRNA levels
were normalized to glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) and expressed as a relative variation from control levels.
All primers for miRNA analysis were purchased from EXIQON, and
primers used for mRNA detection (Metabion) are listed in supple-
mentary methods.
In silico target analysis
Putative mRNA targets for human conserved miRNAs upregulated
in post-synaptic B lymphocytes, summarized in Appendix Table S1,
were identified using the prediction algorithms miRTarBase and
miRanda.
T-cell culture and EV recovery from supernatants
For small RNA sequencing, total splenocytes were isolated from
spleens of 8- to 12-week-old WT C57BL/6 mice. After erythrocyte
lysis, cells were cultured in RPMI supplemented with 10% FBS,
50 lM b-mercaptoethanol, 1 mM sodium pyruvate, and 2 lg/ml
concanavalin A. After 36 h, cells were washed and cultured in RPMI
supplemented with 10% EXO-free FBS and 50 U/ml mrIL-2.
Medium was refreshed every 2 days. EVs were isolated from super-
natants of 6-day lymphoblast cultures by serial ultracentrifugation
[6]. Briefly, cells were pelleted and the supernatant centrifuged at
2,000× g for 20 min. The collected supernatant was subsequently
ultracentrifuged at 10,000× g for 40 min at 4°C (Beckman Coulter
Optima L-100 XP, Beckman Coulter), followed by a final ultracen-
trifugation at 100,000× g for 1 h at 4°C. EVs were resuspended in
PBS for NanoSight analysis or in Laemmli loading buffer for
Western blot analysis [33]. RNA was isolated as described above.
For EV characterization, splenocytes and lymph nodes were
harvested from OT-II mice as described above. Supernatants from
72 h CD4+ T-cell cultures were processed by ultracentrifugation as
previously described, followed by PBS wash, and size-exclusion
chromatography, as described in [34] for analysis of small EVs by
CD3 and CD81 dot-plot and miRNAs content by qPCR, as described
above. For these samples, as non-EVs do not express or express very
low levels of small nucleolar RNAs, the spike-in UniSp6 was used
for normalization.
Flow cytometry and cell sorting
B cells were incubated with the cell tracer CMAC before IS co-
culture. Alternatively, B cells were stained after IS co-culture with
APC-conjugated B220 antibody (BD Pharmingen). B cells were then
isolated by flow cytometry cell sorting in a FACSAria cell sorter,
with elimination of dead cells by DAPI or propidium iodide staining.
Retrovirus-transduced B cells were isolated for RNA extraction and
analysis by sorting for GFP+ cells.
Exosome inhibition
To inhibit exosome secretion, CD4+ T cells isolated from OT-II
mice were pre-incubated with 2 lM manumycin A (Sigma) for
2 h before B-cell co-culture. Alternatively, isolated T cells were
nucleofected with 250 nM of the ON-TARGET plus mouse Rab27a
siRNA-SMART pool (Dharmacon), using the mouse CD4+ T-cell
nucleofector kit (Amaxa). Nucleofected cells were then resus-
pended in complete EXO-free RPMI medium and incubated for
24 h before IS co-culture.
miRNA retroviral transduction
B cells isolated and activated in vitro in the presence of LPS plus
IL-4 were transduced as described in [35]. Briefly, precursor miR-
25-GFP construct vectors were cloned in pMXPIE-Btk by PCR
amplification of genomic DNA isolated from mouse B cells using
the Gentra Puregene cell kit (Qiagen) with specific primers to
amplify the precursor mmu-miR-25 sequence and its flanking
50 bp genomic sequences obtained from miRBase. Retroviral
supernatants were produced by transiently co-transfecting 293T-
HEK cells with pCL-Eco (Imgenex) and pre-miRNA-GFP retroviral
vectors or pMXPIE-Btk retroviral vector, using calcium phosphate
or Lipofectamine 2000 (Thermo Fisher scientific). Mouse primary
B cells were then transduced with retroviral supernatants for 20 h
in the presence of 8 lg/ml polybrene (Sigma), 10 mM Hepes
(Invitrogen), and 50 lM b-mercaptoethanol (Invitrogen). GFP+
cells were sorted at 48 h post-transduction (FACSAria, BD Bios-
ciences) and processed for QIAZOL cell lysis, RNA extraction, and
qPCR analysis. GFP+ cells were stained with DAPI to detect
nuclei, and expression of IgG1, Ki67, and annexin was deter-
mined by flow cytometry.
In vivo adoptive transfer experiments
C57/BL6 WT B cells and CD4+ T cells were isolated from C57/BL6
wild-type mice and their Rab27-KO littermates (see In vitro cell
culture, antibodies, and reagents, above). B cells (6 × 106) and
CD4+ T cells (4 × 106) were adoptively transferred into sublethally
irradiated Rag1-KO mice. At 24 h after reconstitution, mice were
inoculated with 108 sheep red blood cells. After 7 days, splenocytes
were harvested and processed for flow cytometry analysis and sort-
ing of Fas+GL7+ GC center and FasGL7 B cells and CD4+ T cells
for RNA extraction and qPCR analysis. Serum from these mice was
obtained by blood centrifugation for 30 min at 13,000× g and used
for ELISA analysis.
IgG and IgM ELISA
ELISA kits were purchased from Bethyl Laboratories. Absorbance
was measured at 450 nm, with a reference wavelength of
570 nm.
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Data availability
Sequencing data have been deposited in the Gene Expression
Omnibus and are available to readers under record GSE141045;
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE141045.
Expanded View for this article is available online.
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